Patents Assigned to ADAPTIIV MEDICAL TECHNOLOGIES INC.
  • Patent number: 11745028
    Abstract: Systems and methods are provided for generating surface brachytherapy applicators in which catheter channel trajectories are generated laterally from both sides of a cut plane bisecting an initial model of the surface brachytherapy applicator model, thereby mitigating the effects of patient-surface-induced curvature. The catheter channels may be defined based on catheter channel trajectories that are spatially distributed, relative to the cut plane, on both sides of the cut plane, and spatially offset relative to a patient-facing surface of the surface brachytherapy applicator model. In some example embodiments, catheter channel trajectories are spaced relative to the cut plane such that neighbouring catheter channel trajectories are evenly spaced along a set of contours. Prior to fabrication, the local radius of curvature of catheter channels may be adjusted in a manual or automated manner to exceed a threshold.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: September 5, 2023
    Assignee: ADAPTIIV MEDICAL TECHNOLOGIES, INC.
    Inventors: Christopher Majcher, Borko Basaric, James L. Robar
  • Patent number: 11426602
    Abstract: Disclosed herein are systems, methods, and computer-readable storage devices for manufacturing patient-specific bolus for use in targeted radiotherapy treatment. Based on dose calculations without a bolus and based on three-dimensional scan data of a patient, the example system generates a model of a bolus for targeting radiotherapy treatment to a planning target volume or target region within the patient. The system can perform several iterations to generate a resulting model for the bolus. Then, the system can generate instructions for controlling a three-dimensional printer to generate the bolus that conforms to the patient's skin surface while also specifically targeting the planning target volume for the radiotherapy treatment. In this way, the amount of radiotherapy treatment administered to other tissue is reduced, while the costs, time, and human involvement in creating the bolus are significantly reduced.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: August 30, 2022
    Assignee: ADAPTIIV MEDICAL TECHNOLOGIES INC.
    Inventors: James Robar, Shiqin Su